Literature DB >> 17312458

Pancreatic juice cytology and subclassification of intraductal papillary mucinous neoplasms of the pancreas.

Yasuhiro Hibi1, Noriyoshi Fukushima, Akihiko Tsuchida, Atsushi Sofuni, Takao Itoi, Fuminori Moriyasu, Kiyoshi Mukai, Tatsuya Aoki.   

Abstract

OBJECTIVES: Histological subclassification of intraductal papillary mucinous neoplasms (IPMNs) is important because the malignant potential of each subtype is different. We investigated whether pancreatic juice cytology can be used to define the subtypes of IPMNs preoperatively.
METHODS: The cytological findings and pathological parameters in 19 cases of IPMN were analyzed for correlations. Pancreatic juice cytology specimens were reviewed and classified into 4 types according to the criteria previously described for histological diagnosis: intestinal (Int), gastric foveolar (GF), oncocytic (Onc), and pancreatobiliary (PB), and the resected IPMNs were classified histologically using the same criteria for comparison. Immunochemical testing for MUC proteins was also performed.
RESULTS: In 15 cases (79%), the cytological and histological subclassifications were in agreement. The cytology specimens displayed different features corresponded to their histological subtypes. The sensitivities of the cytological diagnosis of each subtype were 80.0% (Int), 72.7% (GF), and 100% (Onc/PB); and the specificities were 85.7% (Int), 87.5% (GF), and 93.8% (Onc/PB). The cytoplasm of the Int-type cells in the pancreatic juice cytology specimens was positive for MUC2.
CONCLUSIONS: Most of the cytological findings of IPMNs corresponded to the histological findings. The use of MUC2 immunocytochemistry in IPMN subtyping was also demonstrated. Subtyping of IPMNs is useful for preoperative evaluation in addition to cytomorphological grading.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17312458     DOI: 10.1097/MPA.0b013e31802dea0

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  13 in total

Review 1.  Molecular pathology of intraductal papillary mucinous neoplasms of the pancreas.

Authors:  Marina Paini; Stefano Crippa; Stefano Partelli; Filippo Scopelliti; Domenico Tamburrino; Andrea Baldoni; Massimo Falconi
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

Review 2.  Controversies in the management of pancreatic IPMN.

Authors:  Masao Tanaka
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-01       Impact factor: 46.802

3.  Low interobserver agreement in cytology grading of mucinous pancreatic neoplasms.

Authors:  Carlie S Sigel; Marcia Edelweiss; Leung Chu Tong; Joanna Magda; Handy Oen; Keith M Sigel; Maureen F Zakowski
Journal:  Cancer Cytopathol       Date:  2014-10-29       Impact factor: 5.284

4.  Pancreatic cyst fluid and serum mucin levels predict dysplasia in intraductal papillary mucinous neoplasms of the pancreas.

Authors:  Ajay V Maker; Nora Katabi; Mithat Gonen; Ronald P DeMatteo; Michael I D'Angelica; Yuman Fong; William R Jarnagin; Murray F Brennan; Peter J Allen
Journal:  Ann Surg Oncol       Date:  2010-08-18       Impact factor: 5.344

5.  Investigation of -PRKACA/-PRKACB fusion genes in oncocytic tumors of the pancreatobiliary and other systems.

Authors:  Yifare Maimaitiaili; Yuki Fukumura; Kenichi Hirabayashi; Yuko Kinowaki; Yoshiki Naito; Akira Saito; Lu Rong; Jun Nakahodo; Takashi Yao
Journal:  Virchows Arch       Date:  2022-09-24       Impact factor: 4.535

6.  Outcome of invasive and noninvasive intraductal papillary-mucinous neoplasms of the pancreas (IPMN): a 10-year experience.

Authors:  Marco Niedergethmann; Robert Grützmann; Ralf Hildenbrand; Dag Dittert; Niloufar Aramin; Melanie Franz; Frank Dobrowolski; Stefan Post; Hans-Detlev Saeger
Journal:  World J Surg       Date:  2008-10       Impact factor: 3.352

7.  Role of pancreatic juice cytology in the preoperative management of intraductal papillary mucinous neoplasm of the pancreas in the era of international consensus guidelines 2012.

Authors:  Takao Ohtsuka; Taketo Matsunaga; Hideyo Kimura; Yusuke Watanabe; Koji Tamura; Noboru Ideno; Teppei Aso; Yoshihiro Miyasaka; Junji Ueda; Shunichi Takahata; Takashi Osoegawa; Hisato Igarashi; Tetsuhide Ito; Yasuhiro Ushijima; Fumihiko Ookubo; Yoshinao Oda; Kazuhiro Mizumoto; Masao Tanaka
Journal:  World J Surg       Date:  2014-11       Impact factor: 3.352

8.  Cytopathologic diagnosis of oncocytic type intraductal papillary mucinous neoplasm: Criteria and clinical implications of accurate diagnosis.

Authors:  Michelle D Reid; Christina R Stallworth; Melinda M Lewis; Gizem Akkas; Bahar Memis; Olca Basturk; Volkan Adsay
Journal:  Cancer Cytopathol       Date:  2015-09-28       Impact factor: 5.284

Review 9.  Elevating pancreatic cystic lesion stratification: Current and future pancreatic cancer biomarker(s).

Authors:  Joseph Carmicheal; Asish Patel; Vipin Dalal; Pranita Atri; Amaninder S Dhaliwal; Uwe A Wittel; Mokenge P Malafa; Geoffrey Talmon; Benjamin J Swanson; Shailender Singh; Maneesh Jain; Sukhwinder Kaur; Surinder K Batra
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2019-10-30       Impact factor: 10.680

Review 10.  Intraductal Papillary Mucinous Neoplasm of Pancreas.

Authors:  Norman Oneil Machado; Hani Al Qadhi; Khalifa Al Wahibi
Journal:  N Am J Med Sci       Date:  2015-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.